Darzalex Faspro 1800mg Vial Of 15ml Injection
Description
Darzalex injection is used in the treatment of multiple myeloma, which is a type of cancer that affects plasma cells. It contains daratumumab, an anticancer medication that targets abnormal cell growth. Darzalex injection can be administered alone or in combination with other cancer treatments.
Infusion reactions, such as a swollen face, lips, mouth, tongue, or throat, along with difficulty swallowing or breathing, are common side effects of this medication. Darzalex injection may decrease the number of blood cells, particularly white blood cells, increasing the risk of infections. Therefore, regular blood tests are necessary to monitor blood cell levels while you are taking this medication. Darzalex injection is not recommended for individuals under the age of 18.
It's important to inform your healthcare team about all medications you are currently using, as many other medicines can interact with this one. This medicine is not recommended for use during pregnancy or while breastfeeding. To prevent pregnancy, it is essential for both males and females to use effective contraception throughout the treatment.
Product Summary
| Offer Price | ₹224910.00 |
| You Save | ₹39690.00 (15% on MRP) |
| Contains | Daratumumab(1800.0 Mg) |
| Uses | Multiple myeloma |
| Side effects | Chills, sore throat, cough, feeling nauseous, vomiting, itchy, runny, or blocked nose, shortness of breath, and infusion-related reactions. |
| Therapy | ANTI-NEOPLASTIC |
Uses
Contraindications
Side effects
- Chills
- Sore throat
- Cough
- Feeling sick (nausea)
- Vomiting
- Itchy, runny, or blocked nose
- Feeling short of breath or other breathing problems
- Infusion-related reactions
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have a history of breathing problems.
- You have had shingles (herpes zoster).
- You have ever had or might now have a hepatitis B infection.
- You get worsening tiredness or yellowing of your skin or white part of your eyes.
- You have hereditary fructose intolerance (HFI).
- You are pregnant or plan to become pregnant.
- You are breastfeeding or plan to breastfeed.
- You have kidney disease or have had a kidney transplant or liver disease.
Directions for Use
Storage and disposal
- Store in a refrigerator (2 °C – 8 °C). Keep the container in the outer carton to protect it from light.
- Keep it out of the reach of children.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
Content Details
Ravindra Ghongade
B. Pharm
Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery), WHO FIDES member
References
- DARZALEX 1800 mg solution for injection - Summary of Product Characteristics (Smpc) - (EMC) [Internet]. Medicines.org.uk. 2025 [cited 30 April 2025]
- Janssen-Cilag Ltd. Patient Information Leaflet: Darzalex 20 mg/mL concentrate for solution for infusion. (EMC); [cited 2025 Apr 30].
- DARZALEX® (daratumumab). Retrieved April 29, 2025
Did you find this medicine information helpful?
Please rate your experience
Other Products from this Brand
Blog Articles
Chronic Condition Articles
Top-Tests we cover:
Top-Selling Healthcare Products:
Top-Selling Medicines:
Top-Searched Medicines:
